LEADER 02305nam  2200553Ia 450 
001 9910789897703321
005 20200520144314.0
010   $a1-61942-402-9
035   $a(CKB)2670000000135203
035   $a(EBL)3017687
035   $a(SSID)ssj0000687526
035   $a(PQKBManifestationID)12265868
035   $a(PQKBTitleCode)TC0000687526
035   $a(PQKBWorkID)10757232
035   $a(PQKB)10132618
035   $a(MiAaPQ)EBC3017687
035   $a(Au-PeEL)EBL3017687
035   $a(CaPaEBR)ebr10654658
035   $a(OCoLC)923653227
035   $a(EXLCZ)992670000000135203
100   $a20110524d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aBreast cancer screening and prevention$b[electronic resource] /$fJonathan D. Pegg, editor
210   $aNew York $cNova Science$dc2011
215   $a1 online resource (144 p.)
225 0 $aCancer etiology, diagnosis and treatments
300   $aDescription based upon print version of record.
311   $a1-61209-288-8 
320   $aIncludes bibliographical references and index.
327   $a""CONTENTS""; ""PREFACE""; ""STRATEGIES FOR PREVENTION OF BREAST CANCER""; ""HEALTH BELIEFS AND BREAST CANCER SCREENING: APPLYING THE STAGE-OF-CHANGE MODELS""; ""BREAST CANCER PERCEPTIONS, KNOWLEDGE AND BEHAVIORAL PRACTICES AMONG WOMEN LIVING IN A RURAL COMMUNITY""; ""ACCESS TO MAMMOGRAPHY FACILITIES AND DETECTION OF BREAST CANCER BY SCREENING MAMMOGRAPHY: A GIS APPROACH""; ""ACCESS TO MAMMOGRAPHY FACILITIES AND BREAST CANCER STAGE AT DIAGNOSIS: DOES GEOGRAPHIC DISTANCE PREDICT?""
327   $a""REDUCTION IN THE RISK OF HUMAN BREAST CANCER BY SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS: FINAL RESULTS OF A CASE CONTROL STUDY""""INDEX""
410  0$aCancer Etiology, Diagnosis and Treatments
606   $aBreast$xCancer$xDiagnosis
606   $aBreast$xCancer$xPrevention
615  0$aBreast$xCancer$xDiagnosis.
615  0$aBreast$xCancer$xPrevention.
676   $a616.99/449075
701   $aPegg$b Jonathan D$01584747
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910789897703321
996   $aBreast cancer screening and prevention$93868715
997   $aUNINA